small molecule chir99021 Search Results


97
MedChemExpress molecule chir99021
Molecule Chir99021, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/molecule chir99021/product/MedChemExpress
Average 97 stars, based on 1 article reviews
molecule chir99021 - by Bioz Stars, 2026-05
97/100 stars
  Buy from Supplier

96
Selleck Chemicals molecule inhibitors
Molecule Inhibitors, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/molecule inhibitors/product/Selleck Chemicals
Average 96 stars, based on 1 article reviews
molecule inhibitors - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

90
Axon Medchem LLC small-molecule inhibitors chir99021
Small Molecule Inhibitors Chir99021, supplied by Axon Medchem LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/small-molecule inhibitors chir99021/product/Axon Medchem LLC
Average 90 stars, based on 1 article reviews
small-molecule inhibitors chir99021 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

98
Tocris small molecule wnt agonist chir99021
Figure 2. Innate Resistance to WNT Signaling in One Daughter Cell Leads to Asymmetric Primitive Streak Specification in Daughter Cell Pairs (A) Overview of the WNT pathway. (B) Stills taken from live imaging of hESCs differentiating toward primitive streak (top); staining of fixed cells reveals asymmetric LEF1 protein expression (bottom). Scale bar represents 10 mm. (C) Ratio of LEF1 protein expression in pairs of daughter cells derived from hESCs exposed to primitive streak differentiation media (ACTIVIN, BMP4, FGF2, and WNT3A); the ratio of LEF1 expression is plotted against the number of hours since the mother cell divided prior to the end of live imaging. Pie charts enumerate the overall percentage of asymmetric versus symmetric daughter cell pairs. (D) Live imaging of hESCs carrying a Tcf/Lef-TurboGFP:NLS:d2PEST reporter allele revealed that upon treatment with primitive streak differentiation media (ACTIVIN, BMP4, FGF2, and WNT3A), WNT/b-catenin signaling is often only activated in one cell in a daughter cell pair. Scale bar represents 10 mm. (E) Ratio of Tcf/Lef-TurboGFP fluorescence in pairs of daughter cells, plotted against the number of hours since the mother cell divided prior to the end of live imaging. Pie charts enumerate the overall percentage of asymmetric versus symmetric daughter cell pairs. (F) MIXL1-GFP hESCs differentiated in primitive streak differentiation media (ACTIVIN, BMP4, FGF2) containing the GSK3 inhibitor <t>CHIR99021</t> (3 mM) still differentiated through asymmetric divisions, as shown by still images from live imaging. Immunostaining of fixed cells revealed that the MIXL1-GFP+ daughter also expressed BRACHYURY protein. Scale bar represents 5 mm. (G and H) Ratio of MIXL1-GFP (G) and BRACHYURY (H) protein expression in pairs of CHIR99021-treated daughter cells, plotted against the number of hours since the mother cell divided prior to the end of live imaging. Pie charts enumerate the overall percentage of asymmetric versus symmetric divisions. Data are representative of three to five independent experiments.
Small Molecule Wnt Agonist Chir99021, supplied by Tocris, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/small molecule wnt agonist chir99021/product/Tocris
Average 98 stars, based on 1 article reviews
small molecule wnt agonist chir99021 - by Bioz Stars, 2026-05
98/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc small molecules chir99021
Figure 2. Innate Resistance to WNT Signaling in One Daughter Cell Leads to Asymmetric Primitive Streak Specification in Daughter Cell Pairs (A) Overview of the WNT pathway. (B) Stills taken from live imaging of hESCs differentiating toward primitive streak (top); staining of fixed cells reveals asymmetric LEF1 protein expression (bottom). Scale bar represents 10 mm. (C) Ratio of LEF1 protein expression in pairs of daughter cells derived from hESCs exposed to primitive streak differentiation media (ACTIVIN, BMP4, FGF2, and WNT3A); the ratio of LEF1 expression is plotted against the number of hours since the mother cell divided prior to the end of live imaging. Pie charts enumerate the overall percentage of asymmetric versus symmetric daughter cell pairs. (D) Live imaging of hESCs carrying a Tcf/Lef-TurboGFP:NLS:d2PEST reporter allele revealed that upon treatment with primitive streak differentiation media (ACTIVIN, BMP4, FGF2, and WNT3A), WNT/b-catenin signaling is often only activated in one cell in a daughter cell pair. Scale bar represents 10 mm. (E) Ratio of Tcf/Lef-TurboGFP fluorescence in pairs of daughter cells, plotted against the number of hours since the mother cell divided prior to the end of live imaging. Pie charts enumerate the overall percentage of asymmetric versus symmetric daughter cell pairs. (F) MIXL1-GFP hESCs differentiated in primitive streak differentiation media (ACTIVIN, BMP4, FGF2) containing the GSK3 inhibitor <t>CHIR99021</t> (3 mM) still differentiated through asymmetric divisions, as shown by still images from live imaging. Immunostaining of fixed cells revealed that the MIXL1-GFP+ daughter also expressed BRACHYURY protein. Scale bar represents 5 mm. (G and H) Ratio of MIXL1-GFP (G) and BRACHYURY (H) protein expression in pairs of CHIR99021-treated daughter cells, plotted against the number of hours since the mother cell divided prior to the end of live imaging. Pie charts enumerate the overall percentage of asymmetric versus symmetric divisions. Data are representative of three to five independent experiments.
Small Molecules Chir99021, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/small molecules chir99021/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
small molecules chir99021 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

95
Tocris small molecules
Figure 2. Innate Resistance to WNT Signaling in One Daughter Cell Leads to Asymmetric Primitive Streak Specification in Daughter Cell Pairs (A) Overview of the WNT pathway. (B) Stills taken from live imaging of hESCs differentiating toward primitive streak (top); staining of fixed cells reveals asymmetric LEF1 protein expression (bottom). Scale bar represents 10 mm. (C) Ratio of LEF1 protein expression in pairs of daughter cells derived from hESCs exposed to primitive streak differentiation media (ACTIVIN, BMP4, FGF2, and WNT3A); the ratio of LEF1 expression is plotted against the number of hours since the mother cell divided prior to the end of live imaging. Pie charts enumerate the overall percentage of asymmetric versus symmetric daughter cell pairs. (D) Live imaging of hESCs carrying a Tcf/Lef-TurboGFP:NLS:d2PEST reporter allele revealed that upon treatment with primitive streak differentiation media (ACTIVIN, BMP4, FGF2, and WNT3A), WNT/b-catenin signaling is often only activated in one cell in a daughter cell pair. Scale bar represents 10 mm. (E) Ratio of Tcf/Lef-TurboGFP fluorescence in pairs of daughter cells, plotted against the number of hours since the mother cell divided prior to the end of live imaging. Pie charts enumerate the overall percentage of asymmetric versus symmetric daughter cell pairs. (F) MIXL1-GFP hESCs differentiated in primitive streak differentiation media (ACTIVIN, BMP4, FGF2) containing the GSK3 inhibitor <t>CHIR99021</t> (3 mM) still differentiated through asymmetric divisions, as shown by still images from live imaging. Immunostaining of fixed cells revealed that the MIXL1-GFP+ daughter also expressed BRACHYURY protein. Scale bar represents 5 mm. (G and H) Ratio of MIXL1-GFP (G) and BRACHYURY (H) protein expression in pairs of CHIR99021-treated daughter cells, plotted against the number of hours since the mother cell divided prior to the end of live imaging. Pie charts enumerate the overall percentage of asymmetric versus symmetric divisions. Data are representative of three to five independent experiments.
Small Molecules, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/small molecules/product/Tocris
Average 95 stars, based on 1 article reviews
small molecules - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier

96
Tocris chir99021
a , Schematic for the direct reprogramming of human astrocytes into neurons. b , Schematic diagram of primary screening protocol to convert human astrocytes into neurons using each of 15 small molecules. AM, Astrocyte Medium; NB, Neurobasal medium. c , Representative images of MAP2 + cells treated with each of 15 small molecules and DMSO as control at day 21. Scale bar, 100 μm. d , Quantification of the percentage of induced MAP2 + neurons treated with 15 small molecules <t>(CHIR99021,</t> Y27632, SB431542, XAV939 and SAG, n = 4 independent experiments; the rest, n = 3 independent experiments) and DMSO (n = 4 independent experiments). Data are presented as mean ± SEM.
Chir99021, supplied by Tocris, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/chir99021/product/Tocris
Average 96 stars, based on 1 article reviews
chir99021 - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

90
Cayman Chemical gsk3-inhibitor chir99021
a , Schematic for the direct reprogramming of human astrocytes into neurons. b , Schematic diagram of primary screening protocol to convert human astrocytes into neurons using each of 15 small molecules. AM, Astrocyte Medium; NB, Neurobasal medium. c , Representative images of MAP2 + cells treated with each of 15 small molecules and DMSO as control at day 21. Scale bar, 100 μm. d , Quantification of the percentage of induced MAP2 + neurons treated with 15 small molecules <t>(CHIR99021,</t> Y27632, SB431542, XAV939 and SAG, n = 4 independent experiments; the rest, n = 3 independent experiments) and DMSO (n = 4 independent experiments). Data are presented as mean ± SEM.
Gsk3 Inhibitor Chir99021, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gsk3-inhibitor chir99021/product/Cayman Chemical
Average 90 stars, based on 1 article reviews
gsk3-inhibitor chir99021 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

86
Exosome Diagnostics molecule inhibitor chir99021
a , Schematic for the direct reprogramming of human astrocytes into neurons. b , Schematic diagram of primary screening protocol to convert human astrocytes into neurons using each of 15 small molecules. AM, Astrocyte Medium; NB, Neurobasal medium. c , Representative images of MAP2 + cells treated with each of 15 small molecules and DMSO as control at day 21. Scale bar, 100 μm. d , Quantification of the percentage of induced MAP2 + neurons treated with 15 small molecules <t>(CHIR99021,</t> Y27632, SB431542, XAV939 and SAG, n = 4 independent experiments; the rest, n = 3 independent experiments) and DMSO (n = 4 independent experiments). Data are presented as mean ± SEM.
Molecule Inhibitor Chir99021, supplied by Exosome Diagnostics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/molecule inhibitor chir99021/product/Exosome Diagnostics
Average 86 stars, based on 1 article reviews
molecule inhibitor chir99021 - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

90
Axon Medchem LLC small-molecule inhibitors pd0325901
a , Schematic for the direct reprogramming of human astrocytes into neurons. b , Schematic diagram of primary screening protocol to convert human astrocytes into neurons using each of 15 small molecules. AM, Astrocyte Medium; NB, Neurobasal medium. c , Representative images of MAP2 + cells treated with each of 15 small molecules and DMSO as control at day 21. Scale bar, 100 μm. d , Quantification of the percentage of induced MAP2 + neurons treated with 15 small molecules <t>(CHIR99021,</t> Y27632, SB431542, XAV939 and SAG, n = 4 independent experiments; the rest, n = 3 independent experiments) and DMSO (n = 4 independent experiments). Data are presented as mean ± SEM.
Small Molecule Inhibitors Pd0325901, supplied by Axon Medchem LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/small-molecule inhibitors pd0325901/product/Axon Medchem LLC
Average 90 stars, based on 1 article reviews
small-molecule inhibitors pd0325901 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Chiron Corporation small molecule chir 99021
a , Schematic for the direct reprogramming of human astrocytes into neurons. b , Schematic diagram of primary screening protocol to convert human astrocytes into neurons using each of 15 small molecules. AM, Astrocyte Medium; NB, Neurobasal medium. c , Representative images of MAP2 + cells treated with each of 15 small molecules and DMSO as control at day 21. Scale bar, 100 μm. d , Quantification of the percentage of induced MAP2 + neurons treated with 15 small molecules <t>(CHIR99021,</t> Y27632, SB431542, XAV939 and SAG, n = 4 independent experiments; the rest, n = 3 independent experiments) and DMSO (n = 4 independent experiments). Data are presented as mean ± SEM.
Small Molecule Chir 99021, supplied by Chiron Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/small molecule chir 99021/product/Chiron Corporation
Average 90 stars, based on 1 article reviews
small molecule chir 99021 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Figure 2. Innate Resistance to WNT Signaling in One Daughter Cell Leads to Asymmetric Primitive Streak Specification in Daughter Cell Pairs (A) Overview of the WNT pathway. (B) Stills taken from live imaging of hESCs differentiating toward primitive streak (top); staining of fixed cells reveals asymmetric LEF1 protein expression (bottom). Scale bar represents 10 mm. (C) Ratio of LEF1 protein expression in pairs of daughter cells derived from hESCs exposed to primitive streak differentiation media (ACTIVIN, BMP4, FGF2, and WNT3A); the ratio of LEF1 expression is plotted against the number of hours since the mother cell divided prior to the end of live imaging. Pie charts enumerate the overall percentage of asymmetric versus symmetric daughter cell pairs. (D) Live imaging of hESCs carrying a Tcf/Lef-TurboGFP:NLS:d2PEST reporter allele revealed that upon treatment with primitive streak differentiation media (ACTIVIN, BMP4, FGF2, and WNT3A), WNT/b-catenin signaling is often only activated in one cell in a daughter cell pair. Scale bar represents 10 mm. (E) Ratio of Tcf/Lef-TurboGFP fluorescence in pairs of daughter cells, plotted against the number of hours since the mother cell divided prior to the end of live imaging. Pie charts enumerate the overall percentage of asymmetric versus symmetric daughter cell pairs. (F) MIXL1-GFP hESCs differentiated in primitive streak differentiation media (ACTIVIN, BMP4, FGF2) containing the GSK3 inhibitor CHIR99021 (3 mM) still differentiated through asymmetric divisions, as shown by still images from live imaging. Immunostaining of fixed cells revealed that the MIXL1-GFP+ daughter also expressed BRACHYURY protein. Scale bar represents 5 mm. (G and H) Ratio of MIXL1-GFP (G) and BRACHYURY (H) protein expression in pairs of CHIR99021-treated daughter cells, plotted against the number of hours since the mother cell divided prior to the end of live imaging. Pie charts enumerate the overall percentage of asymmetric versus symmetric divisions. Data are representative of three to five independent experiments.

Journal: Cell reports

Article Title: Live Imaging Reveals that the First Division of Differentiating Human Embryonic Stem Cells Often Yields Asymmetric Fates.

doi: 10.1016/j.celrep.2017.09.044

Figure Lengend Snippet: Figure 2. Innate Resistance to WNT Signaling in One Daughter Cell Leads to Asymmetric Primitive Streak Specification in Daughter Cell Pairs (A) Overview of the WNT pathway. (B) Stills taken from live imaging of hESCs differentiating toward primitive streak (top); staining of fixed cells reveals asymmetric LEF1 protein expression (bottom). Scale bar represents 10 mm. (C) Ratio of LEF1 protein expression in pairs of daughter cells derived from hESCs exposed to primitive streak differentiation media (ACTIVIN, BMP4, FGF2, and WNT3A); the ratio of LEF1 expression is plotted against the number of hours since the mother cell divided prior to the end of live imaging. Pie charts enumerate the overall percentage of asymmetric versus symmetric daughter cell pairs. (D) Live imaging of hESCs carrying a Tcf/Lef-TurboGFP:NLS:d2PEST reporter allele revealed that upon treatment with primitive streak differentiation media (ACTIVIN, BMP4, FGF2, and WNT3A), WNT/b-catenin signaling is often only activated in one cell in a daughter cell pair. Scale bar represents 10 mm. (E) Ratio of Tcf/Lef-TurboGFP fluorescence in pairs of daughter cells, plotted against the number of hours since the mother cell divided prior to the end of live imaging. Pie charts enumerate the overall percentage of asymmetric versus symmetric daughter cell pairs. (F) MIXL1-GFP hESCs differentiated in primitive streak differentiation media (ACTIVIN, BMP4, FGF2) containing the GSK3 inhibitor CHIR99021 (3 mM) still differentiated through asymmetric divisions, as shown by still images from live imaging. Immunostaining of fixed cells revealed that the MIXL1-GFP+ daughter also expressed BRACHYURY protein. Scale bar represents 5 mm. (G and H) Ratio of MIXL1-GFP (G) and BRACHYURY (H) protein expression in pairs of CHIR99021-treated daughter cells, plotted against the number of hours since the mother cell divided prior to the end of live imaging. Pie charts enumerate the overall percentage of asymmetric versus symmetric divisions. Data are representative of three to five independent experiments.

Article Snippet: Atop this minimal primitive streak induction condition, WNT3A protein (made in house from WNT3A-producing L cells), RSPO2 protein (10–20 ng/mL; R&D Systems), and/or the small-molecule WNT agonist CHIR99021 (3 mM; Tocris) were added as indicated to potentiateWNT signaling and to drive primitive streak specification.

Techniques: Imaging, Staining, Expressing, Derivative Assay, Immunostaining

a , Schematic for the direct reprogramming of human astrocytes into neurons. b , Schematic diagram of primary screening protocol to convert human astrocytes into neurons using each of 15 small molecules. AM, Astrocyte Medium; NB, Neurobasal medium. c , Representative images of MAP2 + cells treated with each of 15 small molecules and DMSO as control at day 21. Scale bar, 100 μm. d , Quantification of the percentage of induced MAP2 + neurons treated with 15 small molecules (CHIR99021, Y27632, SB431542, XAV939 and SAG, n = 4 independent experiments; the rest, n = 3 independent experiments) and DMSO (n = 4 independent experiments). Data are presented as mean ± SEM.

Journal: Nature biomedical engineering

Article Title: Generation of neural organoids for spinal-cord regeneration via the direct reprogramming of human astrocytes

doi: 10.1038/s41551-022-00963-6

Figure Lengend Snippet: a , Schematic for the direct reprogramming of human astrocytes into neurons. b , Schematic diagram of primary screening protocol to convert human astrocytes into neurons using each of 15 small molecules. AM, Astrocyte Medium; NB, Neurobasal medium. c , Representative images of MAP2 + cells treated with each of 15 small molecules and DMSO as control at day 21. Scale bar, 100 μm. d , Quantification of the percentage of induced MAP2 + neurons treated with 15 small molecules (CHIR99021, Y27632, SB431542, XAV939 and SAG, n = 4 independent experiments; the rest, n = 3 independent experiments) and DMSO (n = 4 independent experiments). Data are presented as mean ± SEM.

Article Snippet: From day 3 to day 8, small molecules including CHIR99021 (1.5 μM, Tocris), VPA (5 mM, Cayman), RepSox (1 μM, Tocris), Forskolin (10 μM, Cayman), JQ1 (50 nM, Sigma), ISX-9 (10 μM, Tocris), LDN193189 (100 nM, Stemolecule), TTNPB (0.5 μM, Tocris), Y27632 (10 μM, Tocris), DAPT (2.5 μM, Sigma), SAG (100 nM, EMD Millipore), SB431542 (10 μM, MCE), PD0325901 (10 μM, Tocris), SU5402 (10 μM, Biovision), and XAV939 (10 μM, Tocris) were added to induce neurons cultured with Neural Medium for primary screening.

Techniques: Control

a , Representative images of MAP2 + cells treated with different combinations of small molecules and DMSO. C, CHIR99021; SB, SB431542; R, RepSox; Y, Y27632. Scale bar, 100 μm. b , Quantitative analysis of MAP2 + cells treated with small molecular combinations (CSBY, CSBRY group, n = 4 independent experiments; the rest, n = 3 independent experiments) and DMSO (n = 4 independent experiments). c , Representative images of MAP2 + neurons converted from hESCs-derived astrocytes treated by CSBRY cocktail. Scale bar, 100 μm. d , Quantitative analysis of MAP2 + neurons converted from hESCs-derived astrocytes treated by CSBRY (n = 3 independent experiments). e , Representative images of MAP2 + neurons converted from human mature astrocytes isolated from the patients with glioma treated by CSBRY combination. Scale bar, 100 μm. f , Quantitative analysis of MAP2 + neurons converted from human mature astrocytes isolated from the patients with glioma treated by CSBRY (n = 3 independent experiments). NP: gliomas patient. Data are presented as mean ± SEM. Unpaired Student’s t-test was used for comparing two groups.

Journal: Nature biomedical engineering

Article Title: Generation of neural organoids for spinal-cord regeneration via the direct reprogramming of human astrocytes

doi: 10.1038/s41551-022-00963-6

Figure Lengend Snippet: a , Representative images of MAP2 + cells treated with different combinations of small molecules and DMSO. C, CHIR99021; SB, SB431542; R, RepSox; Y, Y27632. Scale bar, 100 μm. b , Quantitative analysis of MAP2 + cells treated with small molecular combinations (CSBY, CSBRY group, n = 4 independent experiments; the rest, n = 3 independent experiments) and DMSO (n = 4 independent experiments). c , Representative images of MAP2 + neurons converted from hESCs-derived astrocytes treated by CSBRY cocktail. Scale bar, 100 μm. d , Quantitative analysis of MAP2 + neurons converted from hESCs-derived astrocytes treated by CSBRY (n = 3 independent experiments). e , Representative images of MAP2 + neurons converted from human mature astrocytes isolated from the patients with glioma treated by CSBRY combination. Scale bar, 100 μm. f , Quantitative analysis of MAP2 + neurons converted from human mature astrocytes isolated from the patients with glioma treated by CSBRY (n = 3 independent experiments). NP: gliomas patient. Data are presented as mean ± SEM. Unpaired Student’s t-test was used for comparing two groups.

Article Snippet: From day 3 to day 8, small molecules including CHIR99021 (1.5 μM, Tocris), VPA (5 mM, Cayman), RepSox (1 μM, Tocris), Forskolin (10 μM, Cayman), JQ1 (50 nM, Sigma), ISX-9 (10 μM, Tocris), LDN193189 (100 nM, Stemolecule), TTNPB (0.5 μM, Tocris), Y27632 (10 μM, Tocris), DAPT (2.5 μM, Sigma), SAG (100 nM, EMD Millipore), SB431542 (10 μM, MCE), PD0325901 (10 μM, Tocris), SU5402 (10 μM, Biovision), and XAV939 (10 μM, Tocris) were added to induce neurons cultured with Neural Medium for primary screening.

Techniques: Derivative Assay, Isolation